WAVE Life Sciences Ltd (NAS:WVE)
$ 13.41 0.29 (2.21%) Market Cap: 2.05 Bil Enterprise Value: 1.76 Bil PE Ratio: 0 PB Ratio: 14.06 GF Score: 45/100

Q3 2020 WAVE Life Sciences Ltd Earnings Call Transcript

Nov 09, 2020 / 01:30PM GMT
Release Date Price: $7.48 (+3.60%)
Operator

Good morning, ladies and gentlemen, and welcome to the Wave Life Sciences Third Quarter 2020 Earnings Call. (Operator Instructions). As a reminder, this conference call is being recorded.

I would now like to turn the conference over to Graham Morrell, Investor Relations at Wave. Please go ahead.

Graham Morrell

Thank you, operator. Good morning, and thank you for joining us today to discuss our recent business progress to review Wave's Third Quarter 2020 Financial Results. This morning, we issued a news release detailing these results, which is available in the Investors section of our website, www.wavelifesciences.com. The slide presentation that accompanies this webcast will also be available on our website following this call.

Before we begin, I would like to remind you that discussions during this conference call will include forward-looking statements. These statements are subject to a number of risks and uncertainties that could cause our actual results to differ

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot